Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsRaw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Outlook Therapeutics (OTLK) Receivables - Other (2016)

Historic Receivables - Other for Outlook Therapeutics (OTLK) over the last 2 years, with Q2 2016 value amounting to $43350.0.

  • Outlook Therapeutics' Receivables - Other changed N/A to $43350.0 in Q2 2016 from the same period last year, while for Jun 2016 it was $43350.0, marking a year-over-year change of. This contributed to the annual value of $117506.0 for FY2015, which is N/A changed from last year.
  • As of Q2 2016, Outlook Therapeutics' Receivables - Other stood at $43350.0.
  • Outlook Therapeutics' 5-year Receivables - Other high stood at $117506.0 for Q3 2015, and its period low was $43187.0 during Q1 2016.